NCT06476496Completed
Pain Relief With Integrative Medicine (PRIMe)?: Feasibility of Acupuncture for Long COVID
Source: ClinicalTrials.gov · Last updated 12 May 2026
Brief summary (registry, in English)
The goal of this preliminary study is to test methods and procedures to be used in a fully-powered trial to evaluate acupuncture treatment effectiveness. Specifically, we will test the feasibility of conducting a 2-arm randomized clinical trial for evaluating the effectiveness of acupuncture for pain in patients with long COVID. Researchers will compare pain intensity and impact on general activities over 5 months in those who receive acupuncture treatment compared to patients who are receiving usual long COVID care. Participants will complete 4 online surveys at weeks 0, 4, 8, and 20. These surveys include validated mental and physical health questionnaires. Participants who are randomly selected to receive the intervention will receive 8 acupuncture treatment sessions.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 93 (actual)
- First submitted
- 24 Jun 2024
- Start date
- 21 Jun 2024
- Primary completion date
- 30 Mar 2025
- Lead sponsor
- University of Washington
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06476496
What you commit to
- Study type: Interventional
- Participants enrolled: 93
- From 21 Jun 2024 to the primary completion date, 30 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Report baseline level of pain for those who have pre-existing chronic pain (i.e., chronic pain condition(s) present prior to COVID-19 illness AND chronic pain not worsened post-COVID).
- Already received acupuncture treatment for long COVID symptoms.
- Is receiving active cancer therapy
Other illness
- Has seizure disorder with high risk of seizure (i.e., new diagnosis of seizure disorder and/or new medication in the last 3 months, or uncontrolled/unclear triggers for seizures).
Lab values
- Has severe neutropenia (\<500 WBC) due to any cause within the last 6 months
Age
- \<18 years of age at the time of consent.
Other
- Reports absence of pain, pain for less than 12 weeks, or a pain intensity \<4 over the last 7 days.
- Unable to travel to the UW Northgate Clinic once a week for 8 weeks for acupuncture treatments.
- Is currently Pregnant
Who the study is looking for
- ≥ 18 years of age at the time of consent.
- Previous suspected, probable, or confirmed SARS-CoV-2 infection, as defined by the Pan American Health Organization
- Report pain symptoms including musculoskeletal pain (joint, muscle, bone pain), chest pain, abdominal pain, headache, back pain, nerve pain, and pain in ear following a SARS-CoV-2 infection that has persisted for at least 12 weeks and is still present at the time of consent.
- Report pain intensity (0-10 scale) ≥4 in the last 7 days.28
- As of today, has been seen by a clinician in the UW Long COVID Clinic either in-person or via telehealth/virtual visit
- Able to speak and read English and provide informed consent to complete the study requirements.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UW Medicine Primary Care at Northgate Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.